97 related articles for article (PubMed ID: 7656227)
1. Lack of p53 point mutations in chemically induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumor.
Calvert RJ; Tashiro Y; Buzard GS; Diwan BA; Weghorst CM
Cancer Lett; 1995 Aug; 95(1-2):175-80. PubMed ID: 7656227
[TBL] [Abstract][Full Text] [Related]
2. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
3. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma.
Chen TC; Hsieh LL; Kuo TT
J Pathol; 1995 Jul; 176(3):243-7. PubMed ID: 7674087
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of p53 gene in childhood malignant solid tumors.
Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
[TBL] [Abstract][Full Text] [Related]
5. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas.
Ohnishi H; Kawamura M; Hanada R; Kaneko Y; Tsunoda Y; Hongo T; Bessho F; Yokomori K; Hayashi Y
Genes Chromosomes Cancer; 1996 Mar; 15(3):187-90. PubMed ID: 8721685
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
Wang D; Weghorst CM; Calvert RJ; Stoner GD
Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
[TBL] [Abstract][Full Text] [Related]
7. A mutational hot spot in the p53 gene is associated with hepatoblastomas.
Oda H; Nakatsuru Y; Imai Y; Sugimura H; Ishikawa T
Int J Cancer; 1995 Mar; 60(6):786-90. PubMed ID: 7896446
[TBL] [Abstract][Full Text] [Related]
8. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice.
Hegi ME; Söderkvist P; Foley JF; Schoonhoven R; Swenberg JA; Kari F; Maronpot R; Anderson MW; Wiseman RW
Carcinogenesis; 1993 May; 14(5):803-10. PubMed ID: 8504472
[TBL] [Abstract][Full Text] [Related]
9. Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
Rumsby PC; Davies MJ; Evans JG
Mol Carcinog; 1994 Feb; 9(2):71-5. PubMed ID: 8142011
[TBL] [Abstract][Full Text] [Related]
10. [Detection of p53 mutation using PCR-SSCP silver staining method].
Zhao W; Si J; Li K; Zhang X; Song G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the RB tumour suppressor gene in hepatocellular carcinoma and hepatoblastoma cell lines in association with abnormal p53 expression.
Farshid M; Hsia CC; Tabor E
J Viral Hepat; 1994; 1(1):45-53. PubMed ID: 8790559
[TBL] [Abstract][Full Text] [Related]
12. Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors.
Goodrow TL; Storer RD; Leander KR; Prahalada SR; van Zwieten MJ; Bradley MO
Mol Carcinog; 1992; 5(1):9-15. PubMed ID: 1543544
[TBL] [Abstract][Full Text] [Related]
13. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors.
Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM
Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of the APC gene in sporadic hepatoblastomas.
Oda H; Imai Y; Nakatsuru Y; Hata J; Ishikawa T
Cancer Res; 1996 Jul; 56(14):3320-3. PubMed ID: 8764128
[TBL] [Abstract][Full Text] [Related]
16. Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane.
Shivapurkar N; Belinsky SA; Wolf DC; Tang Z; Alabaster O
Cancer Lett; 1995 Sep; 96(1):63-70. PubMed ID: 7553609
[TBL] [Abstract][Full Text] [Related]
17. Aberrations of the p53 tumor suppressor gene in various tumors in dogs.
Setoguchi A; Sakai T; Okuda M; Minehata K; Yazawa M; Ishizaka T; Watari T; Nishimura R; Sasaki N; Hasegawa A; Tsujimoto H
Am J Vet Res; 2001 Mar; 62(3):433-9. PubMed ID: 11277210
[TBL] [Abstract][Full Text] [Related]
18. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
Liu H; Wang Y; Zhou Q; Gui SY; Li X
World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
[TBL] [Abstract][Full Text] [Related]
19. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutational spectra in hepatocellular carcinomas induced by 2-acetylaminofluorene and N-nitroso-2-acetylaminofluorene in rats.
Ho YS; Cheng HT; Wang YJ; Lin JK
Mol Carcinog; 1995 Jul; 13(3):182-90. PubMed ID: 7619221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
